Abingworth Bioventures VII LP
- SEC CIK
- 0001688313
No open-market purchases or sales filed in the past year.
Current role at each company
- JSPR Jasper Therapeutics, Inc.10% Owneras of Feb 12, 2024
- SLNO Soleno Therapeutics Inc10% Owneras of Oct 2, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Abingworth Bioventures VII LP as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
JSPR Jasper Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 (view filing)6:23 PM ET | Feb 8 | 4 days | TC Group, LLC and 9 others10% Owner | PPurchaseVoting Common Stock | +190.0K | $12.95 | +$2.46M | +21.7%1.07M after |